Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study (Bo-CRISP)

Ruhr University of Bochum

Status: Completed

Conditions: Ischemic Stroke

Study type: Observational

Funder types: Other

Identifiers

NCT01843361

Meves-clopi-01

Details and patient eligibility

About

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Enrollment: 159 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• acute ischemic stroke
• admittance to stroke unit
• clopidogrel medication

Exclusion criteria

• no consent
• prior bleeding disorders
• severe liver disorders
• current gastrointestinal disorders
• congestive heart failure
• life-threatening malignancies

Trial design

159 participants in 1 patient group

acute ischemic stroke

Description:

Determing cardiovascular risk factors or medication on clopidogrel response rates after an acute ischemic stroke